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Abstract
Objectives To investigate whether the accelerated
immunisation programme in the United Kingdom is
associated, after adjustment for potential
confounding, with the sudden infant death syndrome.
Design Population based case›control study, February
1993 to March 1996. Parental interviews were
conducted for each death and for four controls
matched for age, locality, and time of sleep.
Immunisation status was taken from records held by
the parents.
Setting Five regions in England with a combined
population of over 17 million.
Subjects Immunisation details were available for 93%
(303/325) of infants whose deaths were attributed to
the sudden infant death syndrome (SIDS); 90%
(65/72) of infants with explained sudden deaths; and
95% (1515/1588) of controls.
Results After all potential confounding factors were
controlled for, immunisation uptake was strongly
associated with a lower risk of SIDS (odds ratio 0.45
(95% confidence interval 0.24 to 0.85)). This
difference became non›significant (0.67 (0.31 to 1.43))
after further adjustment for other factors specific to
the infant’s sleeping environment. Similar proportions
of SIDS deaths and reference sleeps (corresponding
to the time of day during which the index baby had
died) among the controls occurred within 48 hours of
the last vaccination (5% (7/149) v 5% (41/822)) and
within two weeks (21% (31/149) v 27% (224/822)).
No longer term temporal association with
immunisation was found (P = 0.78). Of the SIDS
infants who died within two weeks of vaccination, 16%
(5/31) had signs and symptoms of illness that
suggested that medical contact was required,
compared with 26% (16/61) of the non›immunised
SIDS infants of similar age. The findings for the
infants who died suddenly and unexpectedly but of
explained causes mirrored those for SIDS infants.
Conclusions Immunisation does not lead to sudden
unexpected death in infancy, and the direction of the
relation is towards protection rather than risk.
Introduction
The age at which infants receive their primary course of
immunisation corresponds to the peak age for the inci›
dence of the sudden infant death syndrome, promoting
speculation that these two events might be related. Dur›
ing the past 20 years sporadic reports1–4 and some meth›
odologically weak case›control studies5 6 showed a
possible association. However, a series of studies came to
the opposite conclusion,7–11 and one raised the
possibility that an accelerated immunisation pro›
gramme directly contributed to a reduction in these
deaths.12 All these studies share the weakness that they
may be biased by residual confounding.13 In particular,
an infant who is showing minor symptoms may have
immunisation delayed, and infants from the most
deprived and geographically mobile families are least
likely to be immunised. As these factors may independ›
ently influence the risk of the sudden infant death
syndrome it is essential that they feature in any analysis.
In 1990 the national immunisation programme in
the United Kingdom was accelerated, with immunisa›
tion against diphtheria, tetanus and pertussis, and oral
poliomyelitis given at ages 2, 3, and 4 months
respectively instead of at ages 3, 5, and 9 months. Since
1992 immunisation against Haemophilus influenzae
type b has also been given. The accelerated schedule
was adopted after recognition that a common reason
for low uptake of the vaccine was the mobility of young
families who move out of districts before the children
had completed the primary courses.14 Recent estimates
suggest that 93% of infants complete the primary
course by 1 year of age.15
We conducted a large case›control study of sudden
unexpected death in infancy as part of the Confidential
Enquiry into Stillbirths and Deaths in Infancy (CESDI
SUDI study), after the changes in the immunisation
programme and the reduction in the rate of the
sudden infant death syndrome in the early 1990s.
Findings previously reported from this study suggested
that infants dying of the syndrome and those dying of
explained causes share many of the same underlying
factors, including high levels of deprivation,16 increased
geographical mobility,17 and symptoms of illness in the
24 hours before death.18 We examine here one of the
primary hypotheses of the study—a temporal relation
between the accelerated immunisation programme
and time of death.
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Methods
The methods of the study are described elsewhere.16–20
Briefly, it was a large, population based, case›control
study initially conducted in three former health
regions (the South West, Northern, and Yorkshire
regions) for two years (February 1993 to January 1995)
and expanded (Wessex and Northern regions) for a
third year (April 1995 to March 1996). Ethical approval
was obtained in each region from the local research
ethics committees. The study aimed to include all sud›
den unexpected deaths (both explained and unex›
plained) of infants aged 1 week to 1 year from a total
study population of 17.7 million people. Four age
matched controls for each case were selected.
An interviewer visited each control family
(matched for locality) within a week of the death to
collect the same data as for the index case. A period
of sleep (the “reference sleep”) corresponding to the
time of day during which the index baby had died was
identified in the 24 hours before the interviews of the
control families.
Data were collected on a questionnaire by research
interviewers and from medical records, including
details of immunisation from records held by parents.
A multidisciplinary committee established cause of
death after a full paediatric postmortem examination
to a standard protocol.
A modified form of the Cambridge Baby Check
was included to capture signs and symptoms of illness
in the final 24 hours before death or reference sleep.18
This is a check system to help to quantify illness in
babies; medical contact is suggested if infants score
more than 7.
An infant was considered immunised if he or she
had received any component of the programme before
the last or reference sleep. A conservative estimate of
the uptake of the immunisation programme was calcu›
lated as the proportion of infants who began the pro›
gramme by age 90 days.
Statistical methodology
Data that were not normally distributed were described
by using medians and interquartile ranges. Correlation
was conducted using Pearson’s coefficient. The Mantel›
Haenszel ÷2 test was used to test individual confound›
ers. Odds ratios, 95% confidence intervals, and P values
for the univariate and multivariate analyses were
calculated—with the matching taken into account by
using conditional logistic regression—with the SAS
statistical package.21 Models were constructed with the
stepwise procedure for variables significant at the 5%
level in the univariate analysis.
Results
Ascertainment
Over the three years there were over 470 000 births in
the study area and 456 sudden unexpected deaths in
infancy, of which 363 were attributed to the sudden
infant death syndrome. Interviews were conducted for
325 deaths attributed to the sudden infant death
syndrome (90%), 72 of the 93 explained deaths (77%),
and the controls. Immunisation details were available
for 93% (303/325) of the infants whose deaths were
attributed to the sudden infant death syndrome, 90%
(65/72) of the infants with explained deaths, and 95%
(1515/1588) of controls.
The major causes of death among the 72 explained
deaths were unrecognised infection (46% (33)), acciden›
tal (15% (11)), congenital anomalies (14% (10)), and
non›accidental injury (13% (9)). The causes of the
remaining deaths included metabolic disorders, bowel
obstruction, bronchopulmonary dysplasia, and cardio›
myopathy.
Proportion immunised and potential confounding
Sudden infant death syndrome
Just under half (149/303) of the SIDS infants (infants
whose deaths were attributed to the sudden infant
death syndrome) had begun or completed the
immunisation programme, compared with two thirds
(822/1234) of the controls for the SIDS infants—a sig›
nificant univariate difference (odds ratio 0.48 (95%
confidence interval 0.37 to 0.63)). When adjusted for
matching, this significance increased (0.23 (0.14 to
0.37)). The uptake of the programme, based on infants
aged 3 months or older, was 93% (638/688) among the
control infants and 79% (116/146) among the index
infants. The table stratifies immunisation rates for con›
founding factors that might explain the lower uptake
among SIDS infants. The difference between the SIDS
infants and the control infants was consistent across
the different age groups. The proportion immunised
was similar across the social classes among the
controls, with reduced uptake among the index
families in both the highest and lowest social strata.
Moving house was associated with reduced uptake of
immunisation for both groups. The uptake was slightly
higher among the younger index mothers but not
among the younger control mothers, and lower among
larger families in both index and control families.
Slightly fewer of the control infants with low birth
weight or short gestation had been immunised,
although this was not observed among the index
infants. Increased medical contact either by admission
to a special care baby unit or by subsequent hospital
admission was associated with an increased uptake of
immunisation for both groups; similarly, uptake was
highest for the infants who had experienced a life
threatening event, many of whom were seen by their
doctor. Few infants had a five minute Apgar score less
than 8; of those who did, a higher proportion of the
controls were immunised.
After all of the above confounders were controlled
for, immunisation uptake remained strongly associated
with a lower risk of the sudden infant death syndrome
(multivariate odds ratio 0.45 (0.24 to 0.85)). However,
when we also controlled for highly significant risk fac›
tors in the infant’s sleeping environment for the last or
reference sleep—such as placing the infant prone or
finding the infant with bedclothes over the head—the
difference became non›significant (0.67 (0.31 to 1.43)).
We also analysed the immunisation uptake for a
subgroup of infants subsequently matched for
potential confounding. We selected the infants with
normal birth weight ( > 2500 g) and gestational age
(>37 completed weeks) who had had a normal Apgar
score ( > 7), no history of an apparent life threatening
event, never been admitted to either a special care baby
unit or hospital, and not moved house more than once
in the past year. Preserving the age matching, we chose
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one control infant matched for social class (within one
stratum), maternal age (within five years), and parity
(within one child). The resultant comparison yielded
60 SIDS infants and 60 closely matched controls. In
this subgroup 58% (35) of the SIDS infants were
immunised, compared with 63% (38) of the controls.
At age 3 months or older, the corresponding figures
were 86% (25/29) and 97% (31/32).
Explained deaths
Of the infants who died of explained causes, 54%
(35/65) began or completed the immunisation
programme, compared with 61% (172/281) of
controls (univariate odds ratio 0.51 (0.21 to 1.26)). The
uptake of the programme was 86% (159/184) among
the control infants and 82% (32/39) among the infants
who died of explained causes. Of those who died of
infection, 48% (15/31) were immunised, compared
with 58% (74/128) of controls (0.44 (0.11 to 1.65)).
Temporal comparison
Sudden infant death syndrome
The median age at which the first immunisation was
given was 61 (interquartile range 56›71) days for SIDS
infants and 59 (36›63) days for controls. The observed
higher proportion of immunised controls was consist›
ent over age (figure).
The median time from last immunisation to death
was 27 (16›68) days, similar to the 29 (13›70) days until
interview for controls. Five per cent (7/149) of the
immunised SIDS infants had received a vaccination in
the 48 hours before death; 5% (41/822) of immunised
control infants had received a vaccination in the 48
hours before the reference sleep. With the period
extended to two weeks, the corresponding values were
21% (31/149) and 27% (224/822). The distribution of
the interval between the last vaccination and death or
reference sleep did not seem to yield a particular inter›
val in which a higher proportion of deaths occurred
than expected (P = 0.78).
Explained deaths
Of the infants whose death was explained and who had
begun or completed the immunisation programme,
6% (2/35) died within 48 hours of a vaccination; 3%
(6/172) of the age matched immunised controls had
been vaccinated within 48 hours of the reference sleep.
With the interval extended to two weeks, the
corresponding values were 17% (6/35) and 16%
(28/172). Of the immunised infants who died of infec›
tion, 7% (1/15) had received a vaccination within two
weeks of death, compared with 9% (12/128) of the
immunised controls within two weeks of their
reference sleep.
Signs and symptoms of illness
Sudden infant death syndrome
In the overall study 21% (68/318) of the SIDS infants
scored > 7 on the Baby Check (suggesting that
medical advice or attention would have been required)
in the 24 hours before death, compared with 7% (97/
Controlling for individual potential confounders of immunisation
Potential confounders
Proportion (%) of immunised infants Mantel›Haenszel pooled
odds ratio
(95% confidence interval)SIDS infants Control infants
Overall 149/303 (49) 822/1234 (67) 0.48 (0.37 to 0.63)*
Age of infant (days)†:
<91 33/157 (21) 184/546 (34)
91›120 36/46 (78) 177/200 (89)
>120 80/100 (80) 461/488 (94) 0.43 (0.29 to 0.59)
Socioeconomic group‡:
I and II 18/43 (42) 280/428 (65)
III (non›manual) 44/78 (56) 266/387 (69)
III (manual) and IV 60/114 (53) 215/328 (66)
V and unemployed 27/67 (40) 58/87 (67) 0.50 (0.38 to 0.65)
Moved house in past year:
No 82/159 (52) 651/977 (67)
Once 47/94 (50) 139/204 (68)
Twice or more 20/49 (41) 30/50 (60) 0.51 (0.38 to 0.66)
Maternal age (years):
>29 29/62 (47) 271/410 (66)
25›29 30/75 (40) 305/444 (69)
<25 90/166 (54) 246/380 (65) 0.49 (0.37 to 0.63)
No of children in family:
1 child 47/84 (56) 354/529 (67)
2 or 3 children 80/169 (47) 414/610 (68)
>3 children 22/50 (44) 54/95 (57) 0.50 (0.39 to 0.66)
Birth weight (g):
>2500 116/236 (49) 776/1163 (67)
<2500 33/67 (49) 39/64 (61) 0.50 (0.38 to 0.66)
Gestational age (weeks):
>38 49/104 (47) 453/696 (65)
37›38 70/140 (50) 319/461 (69)
<37 30/58 (52) 41/66 (62) 0.48 (0.37 to 0.63)
Admitted to special care baby unit:
No 112/229 (49) 751/1139 (66)
Yes 37/74 (50) 65/87 (75) 0.47 (0.35 to 0.61)
Admitted to hospital:
No 97/212 (46) 664/1027 (65)
Yes 51/88 (58) 157/206 (76) 0.45 (0.35 to 0.59)
Five minute Apgar score:
>8 139/277 (50) 772/1170 (66)
<8 6/15 (40) 20/25 (80) 0.50 (0.38 to 0.65)
Apparent life threatening event§:
No episodes 128/262 (49) 792/1196 (66)
One episode or more 19/34 (56) 29/37 (78) 0.48 (0.36 to 0.62)
SIDS infants=infants whose deaths were attributed to sudden infant death syndrome.
*Unmatched odds ratio.
†Cut›offs were chosen on the basis of the infants who died within three months (some of who died after
vaccination at age 2 months), those who died aged 3 to 4 months (after the second vaccination), and those
who died after age 4 months and the final vaccination.
‡Based on highest occupational status of parent(s) and previous occupation if currently unemployed.
§Any episode of lifelessness described by the parents.
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1299) of the controls in the 24 hours before the refer›
ence sleep (univariate odds ratio 4.18 (95% confidence
interval 2.73 to 6.39)). Of the SIDS infants who died
within two weeks of immunisation, 16% (5/31) scored
> 7 on the Baby Check, compared with 26% (16/61) of
the non›immunised SIDS infants who were older than
2 months (babies under this age would rarely be
immunised).
Analysing only the infants aged 2 months or older,
we found no correlation, for either the index or the
control group or overall, between the interval from the
last immunisation to death or reference sleep and the
Baby Check score measured in this latter period (Pear›
son’s correlation coefficient 0.01, P = 0.70).
Of the 12 signs and symptoms of illness, only two
were more common among the SIDS infants (but not
controls) who were immunised within two weeks of the
reference sleep than among all the SIDS infants in the
study. Of these 31 immunised infants, 6 were less alert
than usual and 2 had blue fingernails or toenails, but
these proportions were not significantly more than
expected when compared with the non›immunised
infants older than 2 months or with all the SIDS
infants.
Among the infants who scored > 7 on the Baby
Check, 3% (2/68) of the SIDS infants had been immu›
nised within the previous 48 hours, compared with 5%
(5/97) of the controls. The composite Baby Check
score was similar in these two small groups, as were the
signs and symptoms of illness.
Explained deaths
Of the infants who died of explained causes, the
proportion of infants with a high Baby Check score
was even more marked: 65% (20/31) scored > 7, com›
pared with 8% (11/132) of the age matched controls
(univariate odds ratio 22.87 (5.46 to 95.83)). Only one
infant died of an infection within two weeks of immu›
nisation (within 10 days), and this infant had no signs
or symptoms of illness in the 24 hours before death.
Again, we found no correlation between the interval
from the last immunisation to death or reference sleep
and the Baby Check score measured in this period
(Pearson’s correlation coefficient 0.07, P = 0.50).
Discussion
More than a third of the deaths attributed to the
sudden infant death syndrome in this study occurred
between the ages of 2 and 4 months, around the time
that most infants in the United Kingdom were
receiving all three primary immunisations against Hae›
mophilus influenza type b, diphtheria, tetanus and
pertussis, and oral poliomyelitis. For this to be more
than coincidental one would expect a higher immuni›
sation uptake among the infants who died than among
age matched surviving infants, or at least some tempo›
ral pattern compatible with a reaction to immunisa›
tion. The findings from this study suggest the opposite:
fewer infants whose deaths were attributed to the sud›
den infant death syndrome were immunised, and fewer
deaths occurred than expected, both within two days
and two weeks of the last vaccination, with no particu›
lar pattern beyond this time period. The findings for
the infants who died suddenly and unexpectedly but of
explained causes, particularly infections, mirrored
those for the infants whose deaths were attributed to
the sudden infant death syndrome: lower compliance,
no temporal effect, and no correlation between recent
immunisation and signs or symptoms of illness. Our
data suggest that even when potentially confounding
factors, such as family mobility, are taken into account,
immunisation does not contribute to the risk of the
sudden infant death syndrome and may protect
against it.
Possible reactions to immunisation against diph›
theria and tetanus and pertussis include fever,
vomiting, and listlessness.7 Only listlessness was more
common among the infants immunised within two
weeks of death, and this was not significantly more than
expected. In fact, among the infants whose deaths were
attributed to the sudden infant death syndrome and
who were older than 2 months, a greater proportion of
those not immunised showed signs and symptoms of
illness in the 24 hours before death that suggest medi›
cal attention would have been required.
Adjustment for confounding
Previously we have found similar characteristics
among infants whose deaths were attributed to the
sudden infant death syndrome and among those who
died unexpectedly but of explained causes, with social
deprivation and infant illness shortly before death
being strong markers.16 18 A greater proportion of
infants whose deaths were attributed to the sudden
infant death syndrome were from socially deprived
households and from younger, larger families, who
tended to move home more often. These infants were
also vulnerable in terms of problems at birth and
further hospital admissions. However, these potential
confounders did not explain, either individually or col›
lectively, the lower than expected immunisation uptake
among infants whose deaths were attributed to the
sudden infant death syndrome. The uptake among the
control infants reflected the national average (93%) but
the uptake among the infants who died of the
syndrome was 10›15% below this. After further adjust›
ment for other particularly strong associations related
to the infants’ sleeping environment, the difference in
immunisation uptake was not significant but was still in
the direction of immunisation being protective.
Some studies have suggested that immunisation
may bring an increased risk for certain subgroups of
the infant population. A case series conducted by
Walker and colleagues from 1972 to 1983 in the
United States suggested an increased risk of the
sudden infant death syndrome within three days of
primary immunisation for healthy children with
normal birth weights,22 although these findings were
not subsequently confirmed,23 and a study in France
suggested an increased risk among infants under 3
months old.24 In our study, only a fifth of infants aged
under 3 months whose deaths were attributed to the
sudden infant death syndrome had begun the
immunisation programme, compared with a third of
the surviving infants. The subgroup analysis of these
infants, closely matched for socioeconomic and clinical
characteristics with surviving infants, still showed a
lower uptake than expected.
Implications
One possible source of error in previous studies would
be if the effect of immunisation were to increase the
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risk of sudden unexpected deaths that were subse›
quently attributed to infection or other specific causes
and thus not registered as the sudden infant death syn›
drome. We avoided this bias by including all infants
who died suddenly of identified causes.
Shann has suggested, on the basis of observations
from trials in developing countries, that measles vacci›
nation may confer protection from death due to causes
other than measles itself.25 Our data are consistent with
the hypothesis that the standard primary course of
immunisation may also have a non›specific protective
effect on the risk of death in infancy, or alternatively
that failure to begin the course may be a marker of
family organisation where the sudden infant death
syndrome may be more frequent.
We therefore conclude that the accelerated immun›
isation programme in the United Kingdom is not asso›
ciated with sudden unexpected death in infancy,
whether the death is explained or unexplained. These
data re›emphasise the importance of rigorous analysis
of temporal associations of apparent significance.
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What is already known on this topic
Some studies have suggested a link between the
sudden infant death syndrome and primary
immunisation, but most have failed to show a link
Potential bias in the studies includes lack of a
comparative control group with similar low
immunisation uptake and misclassification of
cause of death
What this study adds
This study investigated explained sudden infant
deaths as well as the sudden infant death
syndrome and took into account potential bias
After confounding was controlled for,
immunisation uptake was lowest among the
infants who died, with no temporal relation or
correlation with signs and symptoms of illness
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